EP Patent

EP2012788A4 — PRE-MIXED PRE-MIXED BOLUS IV COMPOSITIONS FOR USE AND METHODS OF USE

Assigned to EKR Therapeutics Inc · Expires 2010-05-26 · 16y expired

What this patent protects

Patent listed against nicardipine-hydrochloride.

Drugs covered by this patent

nicardipine-hydrochloride (NICARDIPINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2012788A4
Jurisdiction: EP
Classification: —
Expires: 2010-05-26
Drug substance claim: No
Drug product claim: No
Assignee: EKR Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.